About DSIP Chemical.

What this site is

DSIP Chemical is a bench sheet on the peer-reviewed research literature on DSIP, the delta sleep-inducing peptide — plain-English, numbers first, every figure logged to its source. It is no clinic and keeps no clinicians; it hands out no medical guidance, issues no prescriptions, and has nothing to sell, supply, or ship. It works only from figures that are already published.

The approach here is data-forward by design: we lead with what the studies measured — the 25 nmol/kg human sleep dose, the ~35% rise in rat delta EEG power, the ~31% wakefulness reduction in a 2024 mouse model — and we attribute every number to its source. Where the evidence is strong, we say so. Where it is thin, weak, or unreplicated, we say that too, because the gaps in the DSIP record are as important as the findings.

Why "Chemical" is in the name

The word "chemical" in "DSIP Chemical" is editorial framing — it signals that this site treats DSIP as what it is, a research chemical with no regulatory approval, rather than a product or a treatment. It is not a claim that the site is a chemical supplier, a laboratory, or a vendor. We sell nothing. The name marks a stance toward the literature: precise, sourced, and unromantic about a compound whose mechanism is still, after four decades, unidentified.

How we handle evidence

Every quantitative claim on this site is tied to a citation you can check on the references page. We distinguish three things carefully and never blur them: published findings (cited to the study), community-reported experiences (clearly labeled anecdotal, not clinical evidence), and honest gaps (the absence of a receptor, of human pharmacokinetics, of modern controlled trials). We do not give dosing instructions, we do not make therapeutic claims, and we describe research in third person — "this dose was given to this species," never "you should take." DSIP is not approved by the FDA or any other regulator for any use.